SI2465533T1 - Methods and compositions comprising supramolecular constructs - Google Patents

Methods and compositions comprising supramolecular constructs

Info

Publication number: SI2465533T1
Authority: SI; Slovenia
Prior art keywords: compositions; methods; supramolecular constructs; supramolecular; constructs
Prior art date: 2004-02-20

Application number

SI200531972T

Other languages

Slovenian (sl)

Inventor

Claude Yves Nicolau

Ruth Greferath

David Hickman

Original Assignee

Ac Immune S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-20

Filing date

2005-02-22

Publication date

2015-07-31

2004-02-20 Priority claimed from US10/783,975 external-priority patent/US20040242845A1/en

2004-10-04 Priority claimed from US10/958,211 external-priority patent/US8663650B2/en

2005-02-22 Application filed by Ac Immune S.A. filed Critical Ac Immune S.A.

2015-07-31 Publication of SI2465533T1 publication Critical patent/SI2465533T1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Microbiology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SI200531972T 2004-02-20 2005-02-22 Methods and compositions comprising supramolecular constructs SI2465533T1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10/783,975 US20040242845A1 (en)	2003-02-21	2004-02-20	Methods and compositions comprising supramolecular antigenic constructs and antibodies elicited against them
US10/958,211 US8663650B2 (en)	2003-02-21	2004-10-04	Methods and compositions comprising supramolecular constructs
EP12153152.9A EP2465533B1 (en)	2004-02-20	2005-02-22	Methods and compositions comprising supramolecular constructs

Publications (1)

Publication Number	Publication Date
SI2465533T1 true SI2465533T1 (en)	2015-07-31

Family

ID=46395388

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200531972T SI2465533T1 (en)	2004-02-20	2005-02-22	Methods and compositions comprising supramolecular constructs

Country Status (10)

Country	Link
JP (1)	JP4934433B2 (en)
KR (1)	KR101277004B1 (en)
CY (1)	CY1116316T1 (en)
DK (1)	DK2465533T3 (en)
ES (2)	ES2539262T3 (en)
HR (1)	HRP20150612T1 (en)
HU (1)	HUE025186T2 (en)
PT (1)	PT2465533E (en)
RS (1)	RS54074B1 (en)
SI (1)	SI2465533T1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI2408807T1 (en) *	2009-03-18	2021-11-30	Ac Immune Sa	Method for therapeutic use
AR083561A1 (en) *	2010-10-26	2013-03-06	Ac Immune Sa	PREPARATION OF AN ANTIGENIC CONSTRUCTION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6187335B1 (en) *	1997-12-31	2001-02-13	Orasomal Technologies, Inc.	Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
WO1999041279A2 (en) *	1998-02-13	1999-08-19	Arch Development Corporation	Methods and compositions comprising the use of blocked b-amyloid peptide
JP5095061B2 (en) *	1999-12-22	2012-12-12	ネクターセラピューティックス	Process for the preparation of 1-benzotriazolyl carbonate of poly (ethylene glycol)

2005
- 2005-02-22 PT PT121531529T patent/PT2465533E/en unknown
- 2005-02-22 RS RS20150393A patent/RS54074B1/en unknown
- 2005-02-22 JP JP2006554250A patent/JP4934433B2/en not_active Expired - Fee Related
- 2005-02-22 SI SI200531972T patent/SI2465533T1/en unknown
- 2005-02-22 ES ES12153152.9T patent/ES2539262T3/en not_active Expired - Lifetime
- 2005-02-22 HU HUE12153152A patent/HUE025186T2/en unknown
- 2005-02-22 KR KR1020127019675A patent/KR101277004B1/en not_active Expired - Fee Related
- 2005-02-22 DK DK12153152.9T patent/DK2465533T3/en active
- 2005-02-22 ES ES05723323T patent/ES2385226T3/en not_active Expired - Lifetime
2015
- 2015-05-25 CY CY20151100465T patent/CY1116316T1/en unknown
- 2015-06-08 HR HRP20150612TT patent/HRP20150612T1/en unknown

Also Published As

Publication number	Publication date
JP4934433B2 (en)	2012-05-16
HK1130698A1 (en)	2010-01-08
ES2539262T3 (en)	2015-06-29
ES2385226T9 (en)	2013-10-10
KR101277004B1 (en)	2013-06-24
CY1116316T1 (en)	2017-02-08
PT2465533E (en)	2015-06-24
RS54074B1 (en)	2015-10-30
JP2007527870A (en)	2007-10-04
HK1172260A1 (en)	2013-04-19
KR20120097546A (en)	2012-09-04
DK2465533T3 (en)	2015-04-20
HRP20150612T1 (en)	2015-07-03
HUE025186T2 (en)	2016-02-29
ES2385226T3 (en)	2012-07-19

Publication	Publication Date	Title
AP2089A (en)	2010-01-11	Compositions and methods for combination antiviraltherapy
ZA200700351B (en)	2008-05-28	Compounds, compositions and methods
GB0422525D0 (en)	2004-11-10	Dermatological compositions and methods
GB0411940D0 (en)	2004-06-30	Methods and compositions
IL181543A0 (en)	2007-07-04	Dendrimer based compositions and methods of using the same
EP1701725A4 (en)	2009-07-01	Methods and compositions
IL191072A0 (en)	2008-12-29	Therapeutic compositions and methods
GB0522287D0 (en)	2005-12-07	Method and compositions
ZA200704295B (en)	2008-08-27	Arthrospira-based compositions and uses thereof
IL182126A (en)	2017-06-29	Compositions containing 5-phenoxyalkoxypsoralen derivatives and uses thereof
EP1968526A4 (en)	2009-10-28	Foamable dental compositions and methods
IL184062A0 (en)	2007-10-31	Visco-supplement composition and methods
EP1807071A4 (en)	2008-01-09	Antipyretic compositions and methods
ZA200608935B (en)	2008-07-30	Methods and compositions for epilation
GB0524927D0 (en)	2006-01-18	Compositions and method
ZA200805079B (en)	2009-08-26	Immunostimulatory compositions and methods
GB0424051D0 (en)	2004-12-01	Compounds and compositions
EP1608970A4 (en)	2006-06-14	Ccn3 compositions and methods
SI2465533T1 (en)	2015-07-31	Methods and compositions comprising supramolecular constructs
GB0501348D0 (en)	2005-03-02	Compositions and methods
ZA200706038B (en)	2008-12-31	Visco-supplement composition and methods
EP1761244A4 (en)	2009-12-09	Isocyanate-based compositions and their use
GB0506035D0 (en)	2005-04-27	Improved formulation
GB0428034D0 (en)	2005-01-26	Compositions and methods
IL179208A0 (en)	2007-03-08	Intereferon formulations